tiprankstipranks
Trending News
More News >
Iradimed Corp (IRMD)
NASDAQ:IRMD
US Market

Iradimed (IRMD) Financial Statements

Compare
174 Followers

Iradimed Financial Overview

Iradimed's market cap is currently $1.25B. The company's EPS TTM is $; its P/E ratio is 59.30; and it has a dividend yield of 1.22%. Iradimed is scheduled to report earnings on January 29, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 73.24M$ 65.56M$ 53.30M$ 41.81M$ 31.72M
Gross Profit$ 56.35M$ 50.16M$ 41.28M$ 32.05M$ 23.57M
Operating Income$ 21.96M$ 20.04M$ 15.63M$ 9.82M$ -756.09K
EBITDA$ 22.78M$ 20.80M$ 16.30M$ 11.22M$ 582.73K
Net Income$ 19.23M$ 17.19M$ 12.83M$ 9.33M$ 1.37M
Balance Sheet
Cash & Short-Term Investments$ 52.23M$ 49.76M$ 57.96M$ 62.50M$ 51.98M
Total Assets$ 98.33M$ 92.16M$ 85.51M$ 82.88M$ 71.07M
Total Debt$ 154.69K$ 2.04M$ 2.21M$ 2.48M$ 2.72M
Net Debt$ -52.08M$ -47.72M$ -55.76M$ -59.52M$ -47.35M
Total Liabilities$ 11.51M$ 20.74M$ 11.84M$ 10.71M$ 9.68M
Stockholders' Equity$ 86.82M$ 71.42M$ 73.67M$ 72.17M$ 61.38M
Cash Flow
Free Cash Flow$ 17.62M$ 5.46M$ 8.17M$ 10.52M$ 5.18M
Operating Cash Flow$ 25.62M$ 13.47M$ 10.04M$ 11.26M$ 5.82M
Investing Cash Flow$ -8.82M$ -8.01M$ -1.37M$ 648.24K$ 246.97K
Financing Cash Flow$ -14.34M$ -13.66M$ -12.71M$ 24.43K$ 522.48K
Currency in USD

Iradimed Earnings and Revenue History

Iradimed Debt to Assets

Iradimed Cash Flow

Iradimed Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.